< Back to search
Filter
New

SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care

for
Cancer, Financial Toxicity
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT07410689

Recruiting
New

tDCS for Late-Life Depression

for
Late Life Depression (LLD),
Location: Dallas TX
Sponsor: Andre Russowsky Brunoni

Sex: All

Age: 60+

Code: NCT07657234

Phase1, Phase2, Recruiting
New

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

for
Primary Progressive Multiple Sclerosis, Primary Progressive MS,
Location: Raleigh NC, Columbus OH, Atlanta GA
Sponsor: Sundance Biosciences, Inc.

Sex: All

Age: 18 - 70

Code: NCT07840326

Phase2, Recruiting
New

Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male Participants

for
Healthy Male Participants
Location: Overland Park KS
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: Male

Age: 18 - 55

Code: NCT07744802

Phase1, Recruiting
New

Feasibility, Usability and Preliminary Efficacy of Home-based FES Fro Adhesive Capsulitis

for
Shoulder Adhesive Capsulitis
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18+

Code: NCT07227662

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

for
Pulmonary Disease, Chronic Obstructive
Location: Tampa FL
Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT07780656

Phase3, Recruiting
New

NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers

for
Advanced Small Intestine Cancer, Appendiceal Cancers
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 18+

Code: NCT07060014

Phase1, Recruiting
Active & ResponsiveNew

Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS

for
Mild Autonomous Cortisol Secretion (MACS),
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07138274

Phase2, Recruiting
New

A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer

for
Prostatic Neoplasms
Location: Plymouth MA, Syracuse NY, Germantown TN, Lafayette LA
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07832292

Phase2, Recruiting
Active & ResponsiveNew

DoubleTake: Effect of Message Exposure Via a Discrete Choice Experiment With Eye-Tracking on Quit Attempts Among Adults Who Smoke Menthol Cigarettes

for
Menthol Cigarettes, Smoking Behavior, Cigarette Use
Location: Atlanta GA
Sponsor: Georgia State University

Sex: All

Age: 21+

Code: NCT07782879

Recruiting
New

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

for
Metastatic Appendix Carcinoma, Metastatic Colorectal Carcinoma,
Location: Goodyear AZ
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07271355

Phase3, Recruiting
Active & ResponsiveNew

Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome

for
Sturge - Weber Syndrome (SWS)
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 0 - 1

Code: NCT07778810

Phase2, Recruiting
New

Autologous Fat Grafting for the Treatment of Chronic Tendinopathy

for
Chronic Tendinopathy
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18 - 70+

Code: NCT07748793

Recruiting
New

A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

for
Asthma
Location: Quebec, Aventura FL, Miami FL, Ajax, Naples FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07645248

Phase3, Recruiting
New

Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma

for
Refractory Clear Cell Renal Cell Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT07748988

Phase1, Recruiting
New

IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced Solid Tumor
Location: East Brunswick NJ, Dallas TX, Los Angeles CA
Sponsor: Fortvita Biologics (USA)Inc.

Sex: All

Age: 18+

Code: NCT06349408

Phase1, Recruiting
Active & ResponsiveNew

Teleneurology Assessment Program for Creutzfeldt-Jakob Disease

for
Creutzfeldt-Jakob Disease (CJD) | Prion Disease
Location: Cleveland OH
Sponsor: University Hospitals Cleveland Medical Center

Sex: All

Age: 18+

Code: NCT07840547

Recruiting
New

Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis

for
Multiple Sclerosis
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 64

Code: NCT07475377

Recruiting
Active & ResponsiveNew

A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033 in Healthy Participants

for
Healthy Volunteers
Location: Salt Lake City UT
Sponsor: Insmed Incorporated

Sex: All

Age: 18 - 50

Code: NCT07765706

Phase1, Recruiting
New

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

for
Prostate Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT07377006

Recruiting